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ABSTRACT The role of inactivation as a central mechanism in blockade of the cardiac Na channel by antiarrhythmic drugs
remains uncertain. We have used whole-cell and single channel recordings to examine the block of wild-type and inactivation-
deficient mutant cardiac Na channels, IFM/QQQ, stably expressed in HEK-293 cells. We studied the open-channel blockers
disopyramide and flecainide, and the lidocaine derivative RAD-243. All three drugs blocked the wild-type Na channel in a
use-dependent manner. There was no use-dependent block of IFM/QQQ mutant channels with trains of 20 40-ms pulses at
150-ms interpulse intervals during disopyramide exposure. Flecainide and RAD-243 retained their use-dependent blocking
action and accelerated macroscopic current relaxation. All three drugs reduced the mean open time of single channels and
increased the probability of their failure to open. From the abbreviation of the mean open times, we estimated association
rates of 106/M/s for the three drugs. Reducing the burst duration contributed to the acceleration of macroscopic current
relaxation during exposure to flecainide and RAD-243. The qualitative differences in use-dependent block appear to be the
result of differences in drug dissociation rate. The inactivation gate may play a trapping role during exposure to some sodium
channel blocking drugs.
INTRODUCTION
Frequency-dependent block of the cardiac Na channel is
central to antiarrhythmic drug action. Rapid beats during
tachycardia are strongly suppressed, whereas the normal
beats are minimally affected. The greater block during re-
petitive excitation indicates the Na channel conformations
occupied during depolarization have greater drug affinity or
more accessible binding sites (Hille, 1977; Hondeghem and
Katzung, 1977; Starmer and Grant, 1985). It is the channel
conformation, not the membrane potential, that enhances
drug binding to the Na channel (Grant et al., 1993). Drugs
bind to open and inactivated channels during membrane
depolarization. Evidence from a wide range of studies sup-
ports the role of the inactivation process in channel block-
ade. Many antiarrhythmic drugs, e.g., the class IB drugs
lidocaine, mexiletine, and amiodarone, produce progressive
block as the duration of depolarization is increased beyond
the initial transient inward current to times when channels
became inactivated (Sanchez-Chapula et al., 1983; Bean et
al., 1983; Clarkson et al., 1988).
Attempts to further define the role of the inactivation
process in block by slowing or disabling inactivation have
produced conflicting results. Superfusion of the cytoplasmic
surface of the sarcolemma with endopeptidases, such as
pronase and chymotrypsin, amino acid-modifying agents,
such as chloramine-T and the pyrethyroid toxins, slow in-
activation (Armstrong et al., 1973; Cohen and Barchi, 1993;
Wang et al., 1987; Wasserstrom et al., 1993). The Na
current assumes a compound waveform, showing an initial
transient component followed by a persistent component,
after treatment with inactivation modifiers. Frequency-de-
pendent block of the persistent component of neuronal Na
current by lidocaine and tetracaine was abolished after
chloramine-T modification, whereas block by the open
channel blockers N-propyl ajmaline and KC 3791 remained
(Zaborovskaya and Khodorov, 1984). Use-dependent block
of neuronal Na channels by ethidocaine and QX314 per-
sisted after chloramine-T treatment, whereas block is abol-
ished after pronase treatment (Wang et al., 1987). Both
modifying agents exerted similar effects on inactivation.
For the cardiac sodium channel, enzymatic removal of in-
activation shifts activation to more negative voltages (Be-
nitah et al., 1996). This shift in activation could influence
drug action (Lawrence et al., 1996). The nonspecific nature
of chemical modification of inactivation may account for
the inconclusive results.
The mutation IFM/QQQ in the linker between the third
and fourth domains (IDIII/IV) of the Na
 channel disables
inactivation (West et al., 1992; Hartmann et al., 1994). This
provides an attractive alternative model for examining the
role in inactivation in channel blockade. Bennett et al.
(1995) showed 80% blockade of the wild-type channel by
25 M lidocaine at a stimulus frequency of 5 Hz, but18%
block of the IFM/QQQ mutant with 100 M lidocaine.
Balser et al. (1996) further showed that lidocaine strongly
suppresses the persistent component of current in this mu-
tant channel, restoring the wild-type phenotype. Based on
their modeling of the change in the current time course, they
indicated that the action of lidocaine could not be explained
by the modulated receptor model of Hille (1977) and
Hondeghem and Katzung (1977). Basler et al. suggested
that antiarrhythmic drugs functioned as allosteric modula-
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tors of channel inactivation, enhancing inactivation at late
times during depolarization. However, current reduction at late
times cannot be uniquely attributed to inactivation or to block.
The role of inactivation in channel block was also exam-
ined by measurement of gating currents in squid giant axon
and cardiac sodium channels. Block of the Na current in
squid giant axon by QX314 immobilizes the same compo-
nent of gating change subjected to physiologic immobiliza-
tion during inactivation (Armstrong & Bezanilla, 1977).
However, in cardiac muscle, the gating current data suggest
drug action on channel activation (Hanck et al., 2000).
There are a number of important unanswered questions
on the role of inactivation in channel blockade using the
IFM/QQQ mutant model. It is not clear whether other
antiarrhythmic drugs, e.g., typical open channel blockers
like disopyramide, also require intact inactivation to effect
use-dependent block. Courtney (1975) has suggested that
the inactivation gate may trap open channel blockers in the
channel pore. If the enhancement of current relaxation in the
IFM/QQQ mutant results from the enhancement of inacti-
vation, it should not be evident with “open-state blockers.”
Alternatively, if a mechanism of local anesthetic action is to
reduce burst duration by enhancing transition into slow
inactivated state(s), the enhanced current relaxation should
be evident with open channel blockers. The need to expand
the class of sodium channel blocking drugs examined in
these mutant channels is made more pressing by the recent
studies by Vedantham and Cannon (1999) suggesting that at
least for the lidocaine-class local anesthetics, it is activation
rather than inactivation that is crucial for block.
We have expressed the wild-type and IFM/QQQ mutant
of the human cardiac Na channel hH1 stably in HEK-293
cells. Using whole-cell and single-channel recordings, we
have examined channel blockade by the open channel
blockers, disopyramide and flecainide, and the lipid-soluble
lidocaine derivative RAD-243. All three drugs block Na
channels with intact inactivation, and disopyramide is also
trapped in the channel. We show that disopyramide blocks
open IFM/QQQ Na channels but produces no use-depen-
dent block. Flecainide blocks open Na channels from a site
accessed from the extracellular space, produces significant
use-dependent block, and accelerates current relaxation like
“inactivated-state blockers”; RAD-243 produces use-depen-
dent block, abbreviates mean channel open time, and en-
hances current relaxation by shortening burst duration. The
role of inactivation in the block of the Na channel by
antiarrhythmic drugs is dependent on kinetics of drug bind-
ing to the channel; it may influence the action of open- and
inactivated-state blockers. Our preliminary results have
been published in abstract form (Grant et al., 1998).
METHODS
Construction of stable cell lines
expressing IFM/QQQ
The human cardiac Na-channel gene, hH1, was cloned into the mamma-
lian expression plasmid pcDNA3. We mutated the triplet IFM in the III–IV
interdomain linker to QQQ using recombinant PCR (Higuchi, 1990).
HEK-293 cells were transfected with the plasmid pcDNA3/hH1QQQ using
lipofectamine. Cells were cultured in DMEM containing 10% FBS, peni-
cillin (100 U/ml), and streptomycin (100 g/ml). G-418 (500 g/ml) was
used as the dominant selective marker. Clones were screened for Na-
channel expression using whole-cell recordings. All three positive clones
isolated showed Na-channel currents with markedly slowed current re-
laxation, but peak current amplitudes were usually 100 pA. The resting
membrane potential of the cells was 60 to 50 mV, i.e., close to the
threshold for Na-channel activation.
We suspected that Ca2 overload secondary to high intracellular [Na]
was suppressing channel expression. In native cells, elevation of [Ca2]i
decreases peak Na current (Chiamvimonvat et al., 1995). Culture in Na-
or Ca2-free medium, high concentrations of TTX, or the membrane-
permeable Ca2-chelator BAPTA-AM resulted in poor cell survival or no
increase in channel expression. In developing neurons, sodium channel
expression is down-regulated by the sodium channel activators veratridine
and -scorpion toxin (Giraud et al., 1998). The process is calcium-inde-
pendent, and mimicked by membrane depolarization. We examined
whether an intervention that could increase membrane potential would
affect current amplitude. We co-transfected HEK-293 cells with the inward
rectifier K channel IRK1 and IFM/QQQ using G-418 and hygromycin as
dominant selective markers. Positive clones expressed Na currents of
0.5 to several nA.
Experimental setup
Whole-cell and single Na-channel currents were measured in HEK-293
cells expressing the wild-type and mutant Na channels. Cells were
superfused with a Na external solution for whole-cell recordings. The
micropipettes were filled with a Cs2 internal solution. Na currents were
the only ionic current recorded under these conditions. Cells were super-
fused with a high-K external solution for the cell-attached single channel
recordings. The high [K] external solution reduced the membrane poten-
tial to 0 mV. Membrane potentials are reported as absolute values. The
major cations in micropipette solution are Na and K. Occasionally we
observed outward single channel currents positive to 30 mV. These
currents were kinetically distinct from the Na channel and we presumed
that these were single K-channel currents. Trials showing such current
were excluded from analysis.
Solutions
The solutions used in these experiments had the following compositions
(mM): Na external solution: NaCl 130, KCl 4, CaCl2 1, MgCl2 5, HEPES
5, and glucose 5 (pH adjusted to 7.4 with NaOH); Cs micropipette
solution: CsCl 130, MgCl2 1, MgATP 5, BAPTA 10, HEPES 10 (pH
adjusted to 7.2 with CsOH); high K external solution: potassium-aspar-
tate 140, KCl 10, MgCl2 2, CaCl2 1, glucose 5, HEPES 5 (pH adjusted to
7.4 with KOH); Na-micropipette solution for single-channel recordings:
NaCl 140, KCl 5, MgCl2 2.5, CaCl2 0.5, HEPES 5 (pH adjusted to 7.4 with
NaOH). All experiments were performed at room temperature (20–22°C).
Antiarrhythmic drugs
We examined the use-dependent blocking action of three sodium channel
blockers. We selected disopyramide as an example of an antiarrhythmic
drug that produces discrete block of open sodium channels, has distinct
structural differences from lidocaine, and has been well studied in native
cells (Sunami et al., 1991; Koumi et al., 1992; Zilberter et al., 1994; Grant
et al., 1996). Flecainide has a pKa of 9.3 and is 99% protonated at pH 7.4.
It blocks sodium channels from an extracellular site; no block is observed
with intracellular application (Nitta et al., 1992). The extent of flecainide
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block does not depend on the duration of depolarization. It is presumed to
be an open channel blocker. However, we are not aware of any studies at
the single channel level demonstrating such block. The third drug we
studied was the lidocaine derivative RAD-243. A butyl group replaces one
of the ethyl substituents on the tertiary amine, increasing lipid solubility
50-fold. It blocks inactivated channels. However, unlike lidocaine, it also
produces discrete open-channel block with intermediate kinetics that can
be readily resolved (Liu et al., 1994). Disopyramide and flecainide were
obtained from Sigma Chemical Co. (St. Louis, MO). RAD-243 was gen-
erously provided by Dr. Rune Sandberg (Astra A Lab, AB, Sodertalije,
Sweden). Disopyramide was prepared as a 102 M stock solution in dilute
HCl. Flecainide was prepared as a 102 stock solution in water. RAD-243
was prepared as a 102 stock solution in DMSO.
Recording techniques
Whole-cell and single-channel recordings were performed with an Axo-
patch-200 or EPC-7 patch clamp amplifier (Axon Instruments, Inc., Foster
City, CA, and Adams and List, Great Neck, NY, respectively). Whole-cell
currents were recorded with 0.5–1.5 M microelectrodes coated with a
hydrophobic elastomer (Sylgard 184) to their tips. Series resistance and
capacitive transients were compensated using standard techniques. At the
beginning of each experiment, adequacy of voltage control was assessed as
previously described (Gilliam et al., 1989). As the peak currents in cells
expressing the IFM/QQQ mutant were usually 2 nA, adequate control
was obtained in all but the rare cell. Whole-cell currents were filtered at 10
kHz and digitized at 20–40 kHz.
Single Na-channel currents were recorded with high-resistance
(10–15 M) microelectrodes. The holding potential was set at 90 mV,
and 200-ms test pulses were applied to 20, 30, 40, and 60 mV.
Currents were filtered at 2.5 kHz and digitized at 20 kHz.
Data analysis
Analysis of the whole-cell and single-channel currents are described in
prior publications from this laboratory (Grant and Starmer, 1987; Grant et
al., 1989). Peak whole-cell currents were determined from digitized cur-
rents using custom software written in C programming language. We
subtracted leakage current and capacity transients before analysis. Currents
during each depolarizing trial were scanned, and the null sweeps collected
and averaged. The averaged null sweep was subtracted from each trial.
Single-channel current amplitude was determined from an all-points his-
togram of the leakage-subtracted currents. Single-channel openings were
identified using an automatic detection algorithm with the threshold set at
0.5 times the single-channel amplitude. Closed times were determined
from trials that had no overlapping openings.
Histograms of open and closed times were fit using a least-square
procedure. The bin width was set at an integer multiple of the sampling
interval (Hurwitz et al., 1991). Open times were usually fit by single-
exponential functions. The distribution of closed times usually required
two exponentials for fitting. Values are quoted as means  SE unless
otherwise stated. Comparisons were made using unpaired or paired t-tests
as appropriate; p  0.05 was considered significant.
RESULTS
The properties of the wild-type sodium channels stably
expressed in HEK-293 cells have been described in prior
studies from this laboratory (Chandra et al., 1998). We shall
first describe the properties of the IFM/QQQ mutant sodium
channel expressed in the same cells. Although the antibiotic
selection should have produced clones of cells, we noted
some variability between cells in the effect of the mutation
on the time course of inactivation. Whole-cell currents from
representative cells are illustrated in Fig. 1, A and C. From
a holding potential of 100 mV, 500-ms conditioning steps
were performed from 100 to 20 mV in 5-mV incre-
ments, each followed by a test depolarization to 20 mV.
Panels A and C show currents at the end of the conditioning
pulse to 100, 80, 60, 40, 20, and the test pulses.
The whole-cell currents in panel A show essentially no
relaxation. The normalized maximum current as a function
of conditioning potential is plotted in panel B; 500-ms
conditioning depolarizations to potentials as low as 20
mV had no effect on maximum current. Clearly, the fast
inactivation process has been removed by the IFM/QQQ
mutation. Currents elicited in another cell from the same
line using the above protocols are illustrated in panel C.
Currents elicited from conditioning potentials of 100 to
60 mV show some inactivation, with a steady-state cur-
rent 63% of the peak current for the most negative condi-
tioning potentials. Conditioning voltages that fail to open
sodium channels elicit very little steady-state inactivation,
suggesting that closed-state inactivation remains disabled. It
is only at potentials to 60 mV, i.e., positive to the current
threshold, that significant inactivation of the current occurs.
As shown in Fig. 1 D, steady-state inactivation is incom-
plete. The potential for half-inactivation of the current was
56 mV. This is 30 mV positive to that of the wild-type
channel expressed in the same cells (Chandra et al., 1998).
The shift is in part a reflection of impaired closed-state
inactivation of the IFM/QQQ mutant channel. We are un-
sure of the basis for the difference in the degree of inacti-
vation between cells. A significant endogenous current
could be contributing to the total current in Fig. 1 C. How-
ever, in nontransfected cells or during the screening process
to identify the positive clones, a majority of cells showed no
endogenous sodium current, or peak currents in the 10–20
pA range. Another possibility is that the cells may produce
a milieu for varying susceptibility to fast and slow modes of
gating (Bennett, 1999). The variable expression of a 1-
subunit could account for contribution of fast and slow
gating modes to the current time course (Lawrence et al.,
1996). However, we are not aware of the expression of an
endogenous 1-subunit in HEK-293 cells. For the remainder
of the reported studies, we tried to select cells expressing
currents of the waveform shown in Fig. 1 A for the analysis
of blockade by antiarrhythmic drugs.
Antiarrhythmic drug blockade of wild-type
sodium channels
Fig. 2 illustrates block of wild-type sodium channels by
disopyramide during pulse train stimulation. Forty pulses of
40-ms duration were applied from 100 to 20 mV at a
cycle length of 150 ms. During control, there was little
difference between the peak current for pulses 1 and 40.
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Exposure to 200 M disopyramide resulted in 21% use-
dependent block. The drug was washed out for 5 min, with
no activating voltage pulses applied during washout. At the
end of the washout period, 1-mV pulses to check the ca-
pacity compensation were applied, followed by the pulse
trains from 100 to 20 mV. A progressive increase in
current was observed between pulses 1 and 40. This repre-
sents use-dependent unblocking. It is not likely to be a
technical artifact of the methods, as the pulse sequence was
immediately repeated and the current during pulses 1 and 40
were virtually superimposable. Data for all pulses during
each of the trains are presented in Fig. 2 D. Block and
recovery were both monoexponential, with rates of 0.098
and 0.1 per pulse, respectively. Fig. 2 E summarizes data
from five experiments during control and disopyramide
exposure and three experiments in which washout of drug
was also obtained.
Disopyramide can also use an intracellular access route to
its blocking site. To contrast this access site with that of
flecainide to be reported below, we performed four exper-
iments in which 200 M disopyramide was included in the
micropipette. After waiting at least 5 min after intracellular
access, pulse train stimulation was applied. Block with
intracellular disopyramide averaged 22  0.4%. In six
separate control cells with no drug in the micropipette, no
use-dependent block was observed. These data are also
summarized in Fig. 2 E.
The same protocols were used to examine block during
exposure to flecainide (Fig. 3). Ten micromolar flecainide
produced 55% use-dependent block during pulse stimula-
tion. The onset of block was relatively slow, with an onset
rate of 0.027/pulse. The drug was then washed out without
interval-depolarizing pulses. The pulse-train applied 5 min
after washout showed similar current during pulses 1 and
40. In contrast to disopyramide, flecainide displayed no
use-dependent unblocking. Summary data are presented in
Fig. 3 E.
We examined a potential intracellular access to its bind-
ing site by including 10 M flecainide in the micropipette
solution. We saw no use-dependent block during pulse-train
stimulation. The tissue bath could act as a large sink for any
drug applied intracellularly. However, the high pKa of 9.3
would force 99% drug into the charged form that would be
retained in the cell. We increased the drug concentration in
FIGURE 1 Variability of macroscopic inactivation in HEK-293 cells expressing the IFM/QQQ mutant cardiac sodium channel. Steady-state inactivation
was determined by applying 500-ms conditioning pulses from a holding potential of 100 mV to various potentials followed by a test pulse to 20 mV.
(A) and (C) show currents at the end of the conditioning and test pulse recorded from separate cells. Vh indicates the overlapping currents during
conditioning potentials of 100, 80, and 60 mV. The maximum (peak) current has been normalized and plotted against the conditioning potential. The
currents in (A) show no inactivation. The currents in (C) show incomplete inactivation. The potential for half-inactivation, V2, was 56 mV; the slope was
factor 5.9 mV.
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the micropipette to 50 M and even after delaying pulse-
train stimulation for 10 min after intracellular access, saw
no use-dependent block with subsequent pulse-train stimu-
lation. When 50 M flecainide was then applied externally
to each cell (i.e., 50 M flecainide inside and outside), 71%
use-dependent block was observed. After washout of the
external flecainide for 5 min, a residual of 11% use-depen-
dent block was evident. Summary data are present in Fig.
3 E. They support the results of Nitta et al. (1992) that flecain-
ide accesses its binding site through an extracellular route.
We examined the use-dependent blocking action of
RAD-243 (extracellular application only) in five experi-
ments. We observed 41 6% (n 6) use-dependent block.
The major difference from disopyramide and flecainide was
that block reached a steady state after few pulses. The rapid
onset of block is similar to that which we reported for native
cells (Barber et al., 1992). No use-dependent unblocking
was observed during washout.
Antiarrhythmic drug blockade of inactivation-
deficient sodium channels: whole-cell studies
Fig. 4 shows whole-cell currents elicited by pulse-train
stimulation in a cell during control, exposure to 200 M
disopyramide, and after washout of the disopyramide. The
holding potential was 100 mV and 20 (P1–P20) 40-ms
test pulses to20 mV were applied at an interpulse interval
of 150 ms. During control (A), there was no significant
relaxation of the current during the pulses and the maximum
current was the same during the first (P1, 0.81 nA) and the
last (P20, 0.8 nA) pulse of the train. During exposure to 200
M disopyramide, peak and plateau current were reduced to
0.56 nA and 0.54 nA for the first and the last pulses of the
train. The reduction in first-pulse current can be attributed to
tonic block, implying block occurring at the resting poten-
tial or block that equilibrated rapidly during the activation
process (duration1 ms). After washout, the maximum and
FIGURE 2 Block of the wild-type cardiac Na channel by disopyramide during pulse-train stimulation. Membrane currents were elicited by 40-ms pulses
from a holding potential of 100 mV to a test potential of 20 mV. The cycle length was 150 ms. Currents during the first and 40th pulses of the train
during control, exposure to disopyramide, and washout of drugs are shown in A–C, respectively. Peak currents during each pulse of the trains are presented
in (D). Block developed at a rate of 0.098 per pulse during drug exposure and unblocking occurred at a rate of 0.1 per pulse after drug washout. Summary
data during both external and internal application of disopyramide are presented in (E). The summary data are presented in a normalized form by dividing
the current during the 40th pulse, P40, by that during the pulse, P1.
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plateau currents recovered (C). The maximum and plateau
current for all 20 pulses in the train are presented in panels
D and E. Disopyramide produces no use-dependent block of
the IFM/QQQ channel. Clearly, the occurrence first-pulse
block is not dependent on the presence of inactivation at the
holding potential (100 mV). The concentration of diso-
pyramide used produces 20–30% use-dependent block of
wild-type cardiac sodium channels (Zilberter et al., 1994).
Summary results are presented in Fig. 5.
Results of an experiment using the same protocol but
with 50 M flecainide are illustrated in Fig. 6. In the
absence of drug, there is a small amount of relaxation of the
current: peak current 0.76 nA, plateau current 0.68 nA for
P1. Again, there is no change in peak and plateau current
during the pulse train in the absence of drugs (Fig. 6, D and
E). This is in striking contrast to the effect observed during
exposure to flecainide. Peak current was reduced to 0.57 nA
and there was a monoexponential relaxation of the current
to a plateau of 0.24 nA. There was little recovery in the peak
current amplitude in the second and subsequent pulses in the
train. The plateau level of P1 was similar to the peak and
plateau levels of P20. As shown in Fig. 6 C, the effect is
partially reversible on washout of flecainide.
From the average block at steady state, bss, the time
constant for the exponential relaxation of the current, b,
and the drug concentration, the association and dissociation
rate constant can be calculated: b  1/(konD  koff); bss 
konD/(konD  koff), where kon and koff are the association
and dissociation rate constants, respectively (KD koff/kon).
From the data in Fig. 5, kon[D]  161.7/s, so kon  3.2 	
106/M/s and koff  88.3/s. This dissociation rate is much
faster than that observed at normal resting potentials in
native cells (Campbell and Vaughan Williams, 1983). De-
activation of the inactivation deficient channel evidently
markedly slows the dissociation of flecainide. Flecainide
retained its use-dependent blocking action in the IFM/QQQ
mutant and resulted in substantial relaxation of the current
despite its lack of inactivated state block.
FIGURE 3 Block of wild-type cardiac Na channels by flecainide during pulse-train. Membrane currents elicited at 20 mV from a holding potential
of 100 mV are illustrated for the first and 40th pulses of the train during control (A), exposure to flecainide (B), and after drug washout (C). Peak current
for all 40 pulses of each train are presented in (D). Summary data for experiments with external, internal (flec in), and combined (flec in and flec out)
exposure to flecainide are presented in (E). For the summary data, peak currents during the 40th pulse, P40, are normalized against those in the first pulse, P1.
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Results with 100 M RAD-243 are shown in Fig. 7,
using protocols as described in Fig. 4. During control, there
was little change of the peak and the plateau currents during
pulse-train stimulation. Exposure to RAD-243 reduced the
peak current from 0.3 nA to 0.14 nA, with progressive
decline of the current during the first pulse. Peak current
during the 20 pulses declined to 0.05 nA. RAD-243 retained
its use-dependent blocking action in the IFM/QQQ mutant
channel. From the rate of relaxation of the current and level
of block at the end of the pulse, we estimated konD  83/s
and koff 17/s. Later, we show that these parameters cannot
account for the substantial first pulse block, and we must
assume that RAD-243 produces 50% tonic block. At the
holding potential of 100 mV, the dissociation of RAD-
243 was sufficiently fast and complete that sodium channel
availability could be determined in a time frame when
currents are stable. Fig. 7 C shows sodium channel avail-
ability at a test potential of 20 mV following 500-ms
conditioning pulses to various potentials. Without drug,
channel availability decreased by 20% at conditioning po-
tentials that open the channel (positive to 60 mV). With
RAD-243, availability declined at a conditioning potential
of85 mV and was zero at55 mV. This experiment does
not distinguish between a shift in availability and voltage-
dependent block during the conditioning pulse.
Antiarrhythmic drug blockade of
inactivation-deficient sodium channels:
single-channel analysis
We performed single-channel current recordings in cell-
attached patches in cells expressing the IFM/QQQ muta-
tion. To record from patches with single active channels, we
used high-resistance electrodes for these recordings.
Patches with a single channel usually were observed in one
of 10 seals. The holding potential was90 mV, and 200-ms
test pulses were applied to 20, 30, 40, and 60 mV.
FIGURE 4 Block of the whole-cell sodium current by disopyramide during pulse-train stimulation. Trains of 20 40-ms pulses from a holding potential
of 100 mV to 20 mV at intervals of 150 ms were applied during control (A), exposure to 200 M disopyramide (B), and after washout of the drug (C).
The current during the first (P1) and the 20th (P20) pulse are shown in A–C. The peak and plateau current for each pulse of the train have been plotted
in (D) and (E). The open circles and C denote data obtained during control; the filled circles and D denote data obtained during disopyramide exposure;
the open triangles and W denote data obtained after washout of disopyramide. Time and current calibrations are shown at the bottom.
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At each test potential, 100–400 trials were performed,
followed by drug, washout, and a repeat of the protocol. The
long-term stability of cell-attached patches dictated that we
limit the number of potentials examined with each drug. The
majority of the single-channel data reported was obtained at
20 and 40 mV.
Single-channel recording during control and exposure to
disopyramide were obtained during continuous recordings
in five cell-attached membrane patches. Currents for five
consecutive trials together with the average current from
100–200 trials are shown in Fig. 8, A–C. The test potential
was 20 mV. The single-channel amplitude was 1.45 pA
during control. For most trials, the single channel present in
this patch showed repetitive openings and closures through-
out the 200-ms pulse. Some of the channel closures during
the bursts were incompletely resolved at the recording band-
width of 2.5 kHz. The average current shows no significant
relaxation during the 200-ms pulse. The mean open time
was 3.8  4.9 ms. During exposure to disopyramide, most
of the bursts still lasted the entire duration of the 200-ms
pulse, and average current showed no relaxation. The open-
ings were interrupted by many rapid closures due to channel
blockade. Mean open time was reduced to 1  1 ms, and
single-channel current amplitude was unchanged at 1.45
pA. The probability that a channel would fail to open during
a depolarizing trial increased from 0.21 during control to
0.28 during exposure to disopyramide. Since the recording
micropipette in this cell-attached recording does not contain
disopyramide, the drug is accessing its binding site through
some intramembrane or cytoplasmic route. As illustrated in
Fig. 8 C, the fast block and reduction of the average current
are reversed on washout of disopyramide.
The distribution of open and closed times is analyzed in
more detail in the histograms shown in Fig. 9. During
control, the distribution of open times was fit by two expo-
nentials, with the slower component (1  0.21/ms) ac-
counting for 30% of the distribution. During exposure to
disopyramide, the distribution was fit with a single expo-
nential with a rate constant  of 1.1/ms, intermediate be-
tween the fast and slow rate constants during control. Com-
paring the two open-time distributions, open times greater
than 5 ms were largely eliminated by disopyramide. The
closed-time distributions during control and disopyramide
exposure were best fit by two exponentials. However, both
distributions were dominated by brief closures that ac-
counted for 98 and 92% of the distribution during control
and drug exposure, respectively. Disopyramide increased
the slow-opening rate constant. Summary data are presented
in Table 1. In two of five experiments, the distribution of
closed times was fit by a single exponential during disopyr-
amide exposure. In the remaining experiments, there was a
trend toward an increase in the slower opening rate (0.71 
0.3/ms and 1  0.16/ms, n  3 during control and disopyr-
amide exposure). The single-channel experiments show that
disopyramide retains its open-channel blocking action in the
IFM/QQQ mutant channels. The absence of use-dependent
block during the whole-cell recordings indicates that the
interstimulus interval of 150 ms is long enough to permit
drug dissociation from its blocking site(s) at the holding
potential of 100 mV.
To our knowledge, single-channel analysis of the block-
ing action of flecainide has not been reported. Since the
drug blocks from the external side of the sarcolemma, the
options for analysis were outside-out patch recordings or
cell-attached recordings with control and drug data obtained
in separate patches (Carmeliet et al., 1989). Outside-out
patches invariably contained multiple channels and were not
suitable for analysis. We elected to compare single-channel
FIGURE 5 Block of whole-cell sodium current by disopyramide, fle-
cainide, and RAD-243 during pulse-train stimulation. In (A) the peak
currents of the last pulse (P20) of pulse trains have been expressed as a
fraction of the current for the first pulse of the train (P1). The ratio is a
measure of the use-dependent block of the sodium current during the trains.
There is little use-dependent reduction of current during control. Signifi-
cant use-dependent block is observed during exposure to flecainide and
RAD-243 only. The ratio for the plateau to steady-state current is plotted
in (B). In both panels, the means were obtained from eight experiments
with disopyramide, four with flecainide, and six with RAD-243; the error
bars are standard errors of the means.
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current in separate control and drug-exposed patches. A
similar strategy was used by Carmeliet et al. (1989) to
examine the blocking action of penticainide in isolated
myocytes. Single-channel currents in separate control and
test patches are shown in Fig. 10. The holding potential was
90 mV and the test potential 20 mV. Each panel shows
current during five consecutive trials and the average cur-
rent from 200 trials. The records are representative of five
experiments in drug-free patches and four test patches in
which the micropipette solution contained 50 M flecain-
ide. The average current in the control patch showed little
change in amplitude during the 200-ms depolarization. In
contrast, the average current in the flecainide-treated patch
declined progressively. Mean open time was 4.1  4.7 ms
in the control patch and 2.3  2.2 ms in the flecainide-
treated patch. Under both recording conditions the distribu-
tion of closed times was biexponential. The fast and slow
rate constants were 0.36 and 5.9/ms for the control patch
and 0.11 and 1.5/ms in the test patch. Probability of failure
to open was 0.07 and 0.56 for the control and test patch,
respectively. Summary data are presented in Table 1. Con-
trol and test data were compared with an unpaired t-test.
Open times were significantly less during flecainide expo-
sure at test potentials of20 and30 mV. The briefer open
times at 40 and 60 mV were not significantly affected
by flecainide. The drug also increased the probability of
failure of the channel to open at 20 and 30 mV. The
distribution of closed times was fit by two exponentials at
test potentials of 20, 30, and 40 mV. One exponential
was required in one of four experiments at a test potential of
60 mV. The slow opening rate  was significantly pro-
longed at 20, and 30 mV in flecainide-exposed patches.
From a direct inspection of the current recording in Fig.
10 B, it is evident that single-channel current amplitude was
not decreasing as the average current relaxed. The current
relaxation can be explained by a shortening of the total burst
duration. Because of hardware limitations, the pulse dura-
tion was limited to 200 ms. Therefore, we can only compare
relative total burst duration, as at least during control most
bursts would have had longer durations if the duration of the
depolarizing pulse were increased. We define the relative
burst duration as the time interval between the first opening
FIGURE 6 Block of the whole-cell sodium current by flecainide during pulse-train stimulation. P1 and P20 are the whole-cell currents during the first
and last pulses of a train of 40-ms pulses from the holding potential of 100 to a test potential of 20 mV. The interpulse interval was 150 ms. Recordings
were obtained during control (A), exposure to flecainide (B), and after washout of flecainide (C). The single exponential fit (time constant 3.57 ms) to the
relaxation of the current during flecainide is superimposed as a dashed line in (B). Peak and plateau currents are plotted in (D) and (E). The open circles
and C denote data obtained during flecainide exposure, and the open triangles and W denote data obtained after washout of the drug. For the first pulse
during flecainide exposure, the current relaxed to a plateau level. There was little decline in the peak and plateau current amplitude during the second and
subsequent pulses.
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and the last closure in a trial. The channel may be open at
the end of the 200-ms pulse, but the last event without
channel closure would be ignored. Using this operational
definition, mean burst duration was 170  4 ms during
control, and 144  8 ms during exposure to flecainide.
Mean burst duration was decreased significantly for the
group of experiments, 170  4 ms during control (n  5)
and 112  14 ms during exposure to flecainide (n  4).
Single-channel conductance for control and test patches
are compared in Fig. 11. Both single-channel I-V relation-
ships were linear with chord conductances of 15.3 and 16 pS
for control and test patches, respectively. The representative
single channel records in panels A and B are consistent with
the data in Fig. 10. Open times are reduced and closed times
increased in the drug-exposed test patches. A qualitative
comparison of the data in Figs. 8, 10, and 11 indicates that
FIGURE 7 Block of the whole-cell
sodium current by RAD-243 during
pulse-train stimulation. P1 and P20
are currents during the first and last
pulses of a train of 40-ms pulses elic-
ited from a holding potential of100
mV to a test potential of 20 mV.
Recordings were obtained during
control (A) and exposure to RAD-243
(B). The peak and plateau currents
for each pulse in the train are plotted
in (C) and (D). The open symbols
and C denote control; the filled sym-
bols and R denote data obtained dur-
ing exposure to RAD-243. The cur-
rent during RAD-243 exposure
declined throughout the 40-ms pulse.
The current at the end of the pulse is
plotted as the plateau current.
FIGURE 8 Effects of disopyramide on single sodium channel currents. Single sodium channel currents were recorded from a cell-attached membrane
patch during control (A), exposure to disopyramide (B), and after washout of the drug (C). The holding potential was 90 mV and the test potential 20
mV. Each panel shows membrane current during five consecutive trials and the average current of 100 trials. There was evidence for a single functioning
channel in this patch.
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at 20 mV, the dissociation rate of flecainide is less than
that of disopyramide.
Single-channel recordings during control and exposure to
RAD-243 were obtained in five cell-attached membrane
patches. Stimulus protocol and recording conditions were
the same as those used for the disopyramide recording. Fig.
12 shows records obtained from a patch during control,
exposure to RAD-243, and after drug washout. The average
current in the lowest row show a clear drug-induced reduc-
tion of the peak current, and progressive decline in current
amplitude for the duration of the 200-ms pulse. Open times
during control and drug exposure were fit with single ex-
ponentials. The mean open times were 3.3 3.6, 1.9 1.9,
and 3.8  3.5 during control, exposure to RAD-243, and
FIGURE 9 Disopyramide action on the open and
closed time distribution. Histograms of open time
during control (A) and exposure to disopyramide (B)
were plotted with a bin width of four sampling inter-
vals (200 s); histograms of closed times were plotted
with a bin width of one sampling interval (50 s). The
distribution of open times during control was fit with
two exponentials, and with one exponential during
disopyramide exposure. Both closed time distribu-
tions were fit with two exponentials. The closing and
opening rate constants are shown in the insets.
TABLE 1 Effects of disopyramide, flecainide, and RAD-243 on single sodium channel properties
Vm (mV) i (pA) 
to (ms) 1 (/ms) 2 (/ms) pf
Data obtained from the same patch
Control (n  5) 20 1.5  0.03 4.4  0.4 —† 0.2  0.03
Disopyramide 1.5  0.04 0.96 0.05* —† 0.4  0.15
Control (n  5) 20 1.6  0.02 3.4 0.6 0.61  0.16 4.76  0.19 0.13  0.06
RAD-243 1.6 0.02 1.6  0.3* 0.55  0.14 3.9  0.65 0.6  0.08*
Control (n  5) 40 2.0  0.02 1.4  0.22 0.09  0.05
RAD-243 1.9  0.04 0.8  0.13 0.52  0.14*
Data obtained from separate patches
Control (n  5) 20 1.6  0.08 4.3  0.3 0.53  0.1 5.5  0.14 0.07 0.015
Flecainide (n  4) 1.4  0.1 1.9  0.54* 0.15  0.05* 3.7  1.0 0.5  0.06*
Control (n  5) 30 1.82  0.1 3.7  0.2 0.62  0.1 4.6  0.25 0.04  0.02
Flecainide (n  4) 1.75  0.18 1.7 0.5* 0.21  0.1* 3.5  1.5 0.47  0.05*
Control (n  5) 40 1.97  0.04 2.1  0.2 0.63  0.12 3.9  0.16 0.14  0.05
Flecainide (n  3) 1.75  0.18 1.7  0.4 0.4  0.3 3.1  0.14 0.46 0.18
Control (n  4) 60 2.26  0.04 0.72  0.1 —† 0.07  0.02
Flecainide (n  3) 2.06  0.04 0.77 0.17 —† 0.26  0.1
Vm, test potential; i, single channel current amplitude; 
to, mean open time; 1 and 2, slow and fast rate constants of closed time distribution; pf, probability
that a channel failed to open.
*p  0.05.
†One or two exponentials required to describe the distribution of closed times.
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drug washout, respectively. Two exponentials were required
to fit the distribution of closed times, but the distributions
were dominated by the faster rate constant; 1 was 0.23,
0.66, and 0.4; and 2 was 5, 4.4, and 4.5. The probability of
failure of the channel to open increased from 0.04 during
control to 0.59 during drug exposure. This was partially
reversed on drug washout (pf  0.17). Summary data from
all five patches are presented in Table 1.
Mean burst duration was 180  4 ms during control and
94  7 ms during exposure to RAD-243. For the five
experiments, apparent burst duration was significantly
shortened, 177  2.7 ms during control and 62  12 ms
FIGURE 10 Flecainide action of single
cardiac sodium channel currents. Membrane
current recorded from separate patches dur-
ing the drug-free state and exposure to fle-
cainide. The holding potential was set at
90 mV and the test potential 20 mV.
Each panel shows current during five con-
secutive trials and the average current of
200 trials.
FIGURE 11 Flecainide action of single sodium channel conductance. The mean single channel current from three to five experiments are plotted against
test potential during control (filled circles) and exposure to flecainide (filled squares) in (A). Exemplar records from drug-free- and flecainide-exposed
patches are shown in (B) and (C), respectively. Single channel chord conductance was 15.3 pS in the drug-free patches, and 16 pS in the flecainide exposed
patches.
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during exposure to RAD-243. The shortening of the appar-
ent burst during drug exposure can account for the marked
relaxation of the macroscopic current. It also indicates that
the channel can close without dissociation of the drug from
the channel. If drug dissociation were required for channel
closure, the apparent duration would have increased (Neher,
1983). An increase in the rate of channel closure during the
200-ms pulse could also contribute to the faster relaxation
of the current during drug exposure. We divided the 200-ms
pulse into five 40-ms segments and compared the mean
open time during each segment. As shown in Fig. 12 B,
mean open time did not decrease during the 200-ms pulse.
This indicates that the mechanism(s) of channel closure is
stationary throughout the pulse.
DISCUSSION
The aim of these studies was the comparison of the block of
cardiac sodium channels with disabled inactivation by a
group of drugs with different blocking mechanisms. Our
studies were performed with the wild-type and IFM/QQQ
mutant human cardiac sodium channel stably expressed in
HEK-293 cells. In preliminary studies, we found the frog
oocyte expression unsuitable for these studies. The wild-
type and IFM/QQQ mutant channels expressed readily.
However, drug response varied markedly and voltage con-
trol was very slow. Cell lines offer the convenience of ready
availability and cells of suitable size and geometry for
whole-cell voltage clamping. Establishing the stable cell
lines of the IFM/QQQ mutant with robust currents proved
formidable. Our initial transfection yielded cells with small
currents of 100 pA. We assumed that sodium overload
from spontaneous channel openings inhibited channel ex-
pression. Drug-induced persistent activation of the sodium
channel or membrane depolarization of developing neurons
also down-regulated sodium channel expression (Giraud et
al., 1998). It was only by co-expression with the inward
rectifier K channel that robust currents were obtained. The
gating of the mutant channel was similar to that previously
reported in frog oocytes (West et al., 1992; Hartmann et al.,
1994; Bennett et al., 1995). There was a small and variable
component of inactivation that persisted in these cells. This
component of inactivation appeared to be dependent on
channel opening. The preparation was adequate to address
the major role of inactivation in channel blockade.
Although block of the sodium channel by disopyramide,
flecainide, and RAD-243 has been examined in native so-
dium channels in prior studies, we have reexamined block
using the wild-type sodium channel in the same heterolo-
gous system as the IFM/QQQ mutant. Disopyramide block
FIGURE 12 RAD-243 action on single sodium channel currents. Single sodium channel currents were recorded form a cell-attached membrane patch
during control (A), exposure to RAD-243 (C), and after washout of drug (D). The holding potential was 90 and the test potential 20 mV. Panels A, C,
and D show currents during five consecutive trials and the average current from 200 trials. The average current shows little time variation during control
and washout, but declined progressively during exposure to RAD-243. The 200-ms pulse was divided into five 40-ms segments, and the mean open time
for events falling in each segment determined. These have been plotted for control (open circle), exposure to RAD-243 (filled circle), and after drug washout
(open triangle). There is no tendency for open times to shorten during the 200 ms, suggesting that the closure mechanism is stationary.
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of wild-type channels developed slowly with either intra or
extracellular application. Reversal of the block following
extracellular drug application required repetitive depolariza-
tion. This is an example of use-dependent unblocking. This
phenomenon of use-dependent unblocking was first de-
scribed by Strichartz in nerve (Strichartz, 1973). It has also
been described for potassium and sodium channel blockers
in nerve and cardiac muscle and heterologously expressed
ion channels (Strichartz, 1973; Carmeliet, 1988; Holmgren
et al., 1997). The interpretation is that drug is trapped
behind the closed activation- or inactivation-gate and re-
quires cycling of the channel through various states to
relieve block. The present experiments do not identify the
actual site of trapping. Onset of block by flecainide was also
very slow, approaching a steady state only after trains of 40
pulses. Our data support extracellular access of flecainide to
its binding site. Both upstroke velocity and whole-cell so-
dium currents have shown that unlike nerve, cardiac sodium
channels are blocked by external application of quaternary
ammonium derivatives of lidocaine. Disopyramide and fle-
cainide have similar pKa values. Therefore, differences in
the state of dissociation are not likely to account for the
difference of access. The absence of use-dependent un-
blocking with flecainide further supports the idea of differ-
ence in pathways for dissociation of the two drugs. RAD-
243 had very rapid onset of block and showed no use-
dependent unblocking.
Disopyramide produced block during the initial depolar-
izing pulse, but no frequency-dependent block in cells that
clearly did not demonstrate any fast inactivation. With the
wild-type channel, there is always the uncertainty that this
initial block reflects block of a small fraction of channels
with residual fast inactivation, tonic block, or rapid block
that attains equilibrium during activation. The experiments
with the IFM/QQQ mutant channel indicate that this initial
block can occur independent of channel inactivation. If we
assume that this initial block reaches equilibrium in the 1
ms (4) required for activation, we can also estimate asso-
ciation and dissociation rates of 5.106/M/s and 2950/s for
the first pulse block, as was implemented for flecainide and
RAD-243. The lack of use-dependent block of the IFM/
QQQ mutant channel by disopyramide differs from the
results of Yeh and Ten Eick (1987) who observed enhanced
use-dependent block with a disopyramide analog in pro-
nase-treated squid giant axons. The most likely explanation
for the differences in results is that pronase produced other
effects on the channel in addition to disabling inactivation.
The single-channel studies confirm the removal of fast
inactivation in the IFM/QQQ mutant. However, there was
some complexity to the gating; open times were not always
well-fit by single exponentials. Closed times were always fit
by two exponentials, indicating that the kinetic scheme
contains at least two closed states. A more appropriate
description of the functional consequence of the IFM/QQQ
mutant is that inactivation becomes freely reversible (Hart-
mann et al., 1994); the channel may then open by the normal








where CN is the terminal resting state, O the open state, I the
inactivated state, and , , , and  the rate constants for the
indicated transitions. In the scheme,  is significant com-
pared with the gating of the wild-type channel.
The single-channel studies provide direct evidence of
block of the IFM/QQQ sodium channel by disopyramide,
despite the absence of use-dependent block. The reduction
of the mean open time during drug exposure provides an
estimate of the association rate constant of 4.106/M/s. The
rate is similar to that which we previously observed in
native cardiac sodium channels (Grant et al., 1993). The
closures and blocking events occurred at similar rates.
Therefore, we could not identify a specific closed-time rate
constant with the blocking events (no prolonged shut peri-
ods between bursts were observed).
The lack of use-dependent block during disopyramide
exposure is consistent with the establishment of equilibrium
of the drug-channel reaction during the initial moment of
the channel activation process. Whether the drug is able to
dissociate from the channel during the repolarization or the
rest potential interval is uncertain. In a prior study of the
block of the whole-cell sodium current in cardiac myocytes
we showed that there were components of disopyramide
block that recovered with fast and slow rates at the resting
potential (Zilberter et al., 1994). In wild-type channels in
which both inactivation and deactivation were slowed by
exposure to the pyrethyroid toxin deltamethrin, we showed
that disopyramide dissociated rapidly (time frame of milli-
seconds) from open sodium channels at the normal resting
potentials (Grant et al., 1993). Kuo and Bean (1994) have
shown that sodium channels are open very briefly on repo-
larization to high membrane potentials. The transient open-
ing on repolarization may provide a pathway for rapid
recovery. The IFM/QQQ mutant may have eliminated the
slow pathway for recovery, but facilitated complete recov-
ery from block in the 150 ms between pulses by an open
channel pathway.
Flecainide retained its use-dependent blocking action in
the IFM/QQQ mutant channel. About 50% block occurs
during the first pulse, and little additional block occurs
during the subsequent pulses of the train. A difference
between the reduction of the peak and the plateau current
may be taken as evidence for differing sensitivities of the
peak and plateau current to be blocked by flecainide (Balser
et al., 1996). An alternative interpretation is a simpler acti-
vated-state blocking model. The monoexponential decline
of the current during P1 of Fig. 6 is consistent with this
interpretation. The single-channel data presented in Fig. 10
and Table 1 also support this interpretation. At 20 and
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30 mV, flecainide reduced the mean single-channel open
time significantly by 50%. Estimated drug association
rates at20 and30 mV were 5.6	 106 and 6	 106/M/s,
respectively. The drug also increased the probability that the
channel would not open during depolarization. The latter
action would scale the average current, but would not alter
the current time course. The slow rate constant for the
distribution of closed times is reduced by flecainide at 20
and 30 mV. The return of channels from the blocked state
is slowed. This contrasts with the action of disopyramide,
which produced no apparent change in the distribution of
closed times.
RAD-243 shared some of the blocking actions of flecain-
ide: rapid relaxation of the current during the first pulse of
the train and use-dependent block during the subsequent
pulses. The rapid relaxation of the current during the pulses
was a result of a shortening of the apparent burst duration.
The reduction of mean open times at 20 and 40 mV are
consistent with association rates of 3.3 and 5.3 	 106/M/s.
The similar association rates estimated from the reduction in
mean open time for all three drugs depends on the assump-
tion that they share the same relationship between drug bulk
and receptor-site concentration. In view of the marked dif-
ferences in drug lipid solubility and pKa, such an assump-
tion may not be warranted. Drug dissociation should not
depend on this assumption; the difference in the extent of
use-dependent blockade may more directly reflect differ-
ences in dissociation rate of the drug from the channel.
We have explored mechanisms of blockade using the
Lou-Rudy model, which includes the Ebihara-Johnson Na
channel model. We disabled inactivation by setting the fast
(h) variables to one. Using m as the activation variable, we
defined the drug alterations of the sodium current with
I(Na) gNa*m*(1 b)*(V VNa), where b is the fraction
of blocked channels. We explored a model of blockade
based on dynamic control of the channel-binding site. Be-
cause inactivation was absent, we limited our exploration to
that where activation controlled binding site access and is




where kon is the association rate constant, D is the drug
concentration, m is the channel activation variable, koff is
the dissociation rate constant, and b is the fraction of
blocked channels.
From the whole-cell recordings, we estimated the rate
constants for block at the test potential of20 mV by fitting
an exponential to the decreasing phase of the sodium current
in order to evaluate the time constant. The results were:
Disopyramide:
konD	 1.05/ms koff	 2.95/ms kon	 5  106/M/s
Flecainide:
konD	 0.16/ms koff	 0.088/ms kon	 3.2  106/M/s
RAD-243:
konD	 0.083/ms koff	 0.017/ms kon	 8.3  105/M/s
In Fig. 13 we show the results of the numerical studies,
showing good agreement with the observed currents.
The simulations suggest association rates that are of
similar order of magnitude to those observed with the sin-
gle-channel recordings. However, the routes of access to the
receptor may differ between the whole-cell and single-
FIGURE 13 Simulations of block of the
IFM/QQQ mutant sodium channel by disopyr-
amide (diso), flecainide, and the lidocaine de-
rivative RAD-243. The simulations were im-
plemented using the Ebihara-Johnson sodium
current model as contained in the Lou-Rudy
model. The fast and slow inactivation rates
have been set to zero and the association rates
optimized from a fit of the macroscopic
currents.
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channel recordings. The greatest uncertainties are the rates
for disopyramide, as the reduction of first-pulse current
amplitude with this drug may truly reflect tonic block.
Dissociation rates should be concentration-independent, and
the simulations suggest almost a 200-fold variation between
them. The fastest dissociation rate was for disopyramide,
which showed considerable flicker in the single-channel
recordings. The dissociation rate for flecainide was 30-
fold less, which would result in a decreased number of
channel openings (Fig. 9) during the depolarizing trials.
Little rest-recovery occurred between pulses, suggesting
that the drug may be trapped by closure of the activation
gate. RAD-243, however, dissociates roughly four times
slower, but appears not to be trapped in the channel. The
results with RAD-243 indicate that there are probably two
binding processes for lidocaine and lidocaine derivatives:
one that is associated with a tonic component of block and
a second component of slow block that accounts for relax-
ation of the current during the depolarizing pulses. That
both types of binding exist has also been suggested by
experiments in sodium channels with intact inactivation or
chemically modified channels (Gilliam et al., 1989; Ging-
rich et al., 1993). Confirming these results, Starmer et al.
(1991) demonstrated that both the channel availability and
current-voltage curves were shifted in a manner consistent
with binding site access controlled by the inactivation volt-
age sensor and the activation voltage sensor (Starmer et al.,
1991).
Our results need to be reconciled with the earlier studies
of Bennett et al. (1995), Balser et al. (1996), and Vedantham
and Cannon (1999) on the block of inactivation-deficient
sodium channel (IFM/QQQ or IFM/IQM) by lidocaine.
Bennett et al. observed no use-dependent block with 100
M lidocaine. We believed that the differences in our
observations and those of Bennett et al. are largely quanti-
tative. As shown in their Fig. 8, they did observe block with
higher lidocaine concentrations. They showed a similar
increase in the current relaxation rate that could be fit to an
activated-state blocking model. The additional requirement
for tonic block in our model is consistent with our prior
studies in native cells showing that RAD-243 produces a
substantial amount of tonic block when compared with
lidocaine (Liu et al., 1994). Our interpretation of the in-
crease in relaxation rate with different reductions of the
peak and plateau current is different from that of Balser et
al. (1996). Their model assumed different KD values for the
reduction of the peak and plateau current. However, since
they did not show that an equilibrium was achieved at the
peak of the current, a KD value cannot be estimated for the
reduction of the peak current. Some tonic block and a single
fixed KD value are enough to capture the change in current
time course. Furthermore, the single-channel studies sug-
gest that the blocking mechanism is stable during the
200-ms pulse (Fig. 12).
Vedantham and Cannon (1999) report no effect of lido-
caine on the apparent rate of recovery of lidocaine-blocked
sodium channel from inactivation. This was inferred from
the reactivity of the ICM mutant to modification by MTS-ET.
However, their estimate of the reaction time constant was
0.027/s. We are concerned that the measurement may not
have had the requisite precision to follow the inactivation
process, which has a time constant of 5 ms. Furthermore,
the kinetics of the modifying reaction was of the same order
of our blocking rate of 106/M/s. We agree with their con-
clusion that the ICM mutation may have changed the rela-
tionship between drug blockade and inactivation. Our
results with disopyramide are consistent with such a con-
clusion (Grant et al., 1996). We can clearly demonstrate
open block of wild-type and mutant sodium channels, but
use-dependence is lost with the IFM/QQQ mutant. Prior
studies of inactivation-deficient mutant sodium channels
suggest no change in channel activation (Hartmann et al.,
1994). Therefore, we cannot make a compelling case for a
change in activation as a basis for the change in use-
dependent block. Our studies suggest that the local anes-
thetic-class drugs cannot be regarded as a uniform class.
Although they may share common receptors, there may be
important differences in their access and mode of block at
their receptor site(s).
REFERENCES
Armstrong, C. M., and F. Bezanilla. 1977. Inactivation of the sodium
channel. II. Gating current experiments. J. Gen. Physiol. 70:567–590.
Armstrong, C. M., F. Bezanilla, and E. Rojas. 1973. Destruction of sodium
conductance inactivation in squid axons perfused with pronase. J. Gen.
Physiol. 62:375–391.
Balser, J. R., H. B. Nuss, D. W. Orias, D. C. Johns, E. Marban, G. F.
Tomaselli, and J. H. Lawrence. 1996. Local anesthetics as effectors of
allosteric gating. J. Clin. Invest. 98:2874–2886.
Barber, M. J., D. J. Wendt, C. F. Starmer, and A. O. Grant. 1992. Blockade
of cardiac sodium channels. Competition between the permeant ion and
antiarrhythmic drugs. J. Clin. Invest. 90:368–381.
Bean, B. P., C. J. Cohen, and R. W. Tsien. 1983. Lidocaine block of cardiac
sodium channels. J. Gen. Physiol. 81:613–642.
Benitah, J.-P., G. F. Tomaselli, and E. Marban. 1996. Adjacent pore-lining
residues with sodium channels identified by paired cysteine mutagene-
sis. Proc. Natl. Acad. Sci. USA. 93:7392–7396.
Bennett, E. S. 1999. Effects of channel cytoplasmic regions on the activa-
tion mechanisms of cardiac versus skeletal muscle Na channels. Bio-
phys. J. 77:2999.
Bennett, P. B., C. Valenzuela, L.-Q. Chen, and R. G. Kallen. 1995. On the
molecular nature of the lidocaine receptor of cardiac Na channels. Circ.
Res. 77:584–592.
Campbell, T. J., and E. M. Vaughan Williams. 1983. Voltage- and time-
dependent depression of maximum rate of depolarization of guinea-pig
ventricular action potential by two new antiarrhythmic drugs, flecainide
and lorcainide. Cardiovasc. Res. 17:251–258.
Carmeliet, E. 1988. Activation block and trapping of penticainide, a
disopyramide analogue, in the Na channel of rabbit cardiac Purkinje
fibers. Circ. Res. 63:50–60.
Carmeliet, E., B. Nilius, and J. Vereecke. 1989. Properties of the block of
single Na channels in guinea-pig ventricular myocytes by the local
anesthetic penticainide. J. Physiol. 409:241–262.
3034 Grant et al.
Biophysical Journal 79(6) 3019–3035
Chandra, R., C. F. Starmer, and A. O. Grant. 1998. Multiple effects of KPQ
deletion mutation on gating of human cardiac Na channels expressed in
mammalian cells. Am. J. Physiol. Heart Circ. Physiol. 274:
H1643–H1654.
Chiamvimonvat, N., M. E. Kargacin, R. B. Clark, and H. J. Duff. 1995.
Effects of intracellular calcium on sodium current density in cultured
neonatal rat cardiac cyocytes. J. Physiol. 483.2:307–318.
Clarkson, C. W., C. H. Follmer, R. E. Ten Eick, L. M. Hondeghem, and
J. Z. Yeh. 1988. Evidence for two components of sodium channel block
by lidocaine in isolated cardiac myocytes. Circ. Res. 63:869–878.
Cohen, S. A., and R. L. Barchi. 1993. Voltage-dependent sodium channels.
Internat. Rev. Cytol. 137C:55–103.
Courtney, K. R. 1975. Mechanism of frequency-dependent inhibition of
sodium currents in frog myelinated nerve by the lidocaine derivative
GEA 968. J. Pharmacol. Exp. Ther. 195:225–236.
Gilliam, F. R., C. F. Starmer, and A. O. Grant. 1989. Blockade of rabbit
atrial sodium channels by lidocaine: characterization of continuous and
frequency-dependent blocking. Circ. Res. 65:723–739.
Gingrich, K. J., D. Beardsley, and D. T. Yue. 1993. Ultra-deep blockade of
Na channels by a quaternary ammonium ion: catalysis by a transition-
intermediate state? J. Physiol. 471:319–341.
Giraud, P., G. Alcaraz, F. Jullien, B. Sampo, E. Jover, F. Couraud, and B.
Dargent. 1998. Multiple pathways regulate the expression of genes
encoding sodium channel subunits in developing neurons. Mol. Brain
Res. 56:238–255.
Grant, A. O., R. Chandra, and C. Keller. 1998. Stable expression of the
IFM/QQQ inactivation-deficient mutant Na channel in mammalian cells
and its block by disopyramide. Circulation. 98:55 (Abstr.).
Grant, A. O., M. A. Dietz, F. R. Gilliam, and C. F. Starmer. 1989. Blockade
of cardiac sodium channels by lidocaine: single channel analysis. Circ.
Res. 65:1247–1262.
Grant, A. O., J. E. John, V. V. Nesterenko, and C. F. Starmer. 1996. The
role of inactivation in open-channel block of the sodium channel: studies
with inactivation-deficient mutant channels. Mol. Pharmacol. 50:
1643–1650.
Grant, A. O., and C. F. Starmer. 1987. Mechanisms of closure of cardiac
sodium channels in rabbit ventricular myocytes: single-channel analysis.
Circ. Res. 60:897–913.
Grant, A. O., D. J. Wendt, Y. Zilberter, and C. F. Starmer. 1993. Kinetics
of interaction of disopyramide with the cardiac sodium channel: fast
dissociation from open channels at normal rest potentials. J. Membr.
Biol. 136:199–214.
Hanck, D. A., J. C. Makielski, and M. F. Sheets. 2000. Lidocaine alters
activation gating of cardiac Na channels. Pflugers Arch. Eur. J. Physiol.
439:814–821.
Hartmann, H. A., A. A. Tiedeman, S.-F. Chen, A. M. Brown, and G. E.
Kirsch. 1994. Effects of III–IV linker mutations on human heart Na
channel inactivation gating. Circ. Res. 75:114–122.
Higuchi, R. 1990. Recombinant PCR. In PCR Protocols: A Guide to
Methods and Applications. Academic Press, San Diego. 177–183.
Hille, B. 1977. Local anesthetics: hydrophilic and hydrophobic pathways
for the drug-receptor reaction. J. Gen. Physiol. 69:497–515.
Holmgren, M., P. L. Smith, and G. Yellen. 1997. Trapping of organic
blockers by closing of voltage-dependent K channels: evidence for a
trap door mechanism of activation gating. J. Gen. Physiol. 109:527–535.
Hondeghem, L. M., and B. G. Katzung. 1977. Time- and voltage-
dependent interactions of antiarrhythmic drugs with cardiac sodium
channels. Biochim. Biophys. Acta. 472:373–398.
Hurwitz, J. L., M. A. Dietz, C. F. Starmer, and A. O. Grant. 1991. A source
of bias in the analysis of single channel data: assessing the apparent
interaction between channel proteins. Comput. Biomed. Res. 24:
584–602.
Koumi, S.-I., R. Sato, I. Hisatome, H. Hayakawa, H. Okumura, and R.
Katori. 1992. Disopyramide block of cardiac sodium current after re-
moval of the fast inactivation process in guinea pig ventricular myo-
cytes. J. Pharmacol. Exp. Ther. 261:1167–1174.
Kuo, C.-C., and B. D. Bean. 1994. Na channels must deactivate to recover
from inactivation. Neuron. 12:819–829.
Lawrence, J. H., D. W. Orias, J. R. Balser, H. B. Nuss, G. F. Tomaselli, B.
O’Rourke, and E. Marban. 1996. Single-channel analysis of inactiva-
tion-defective rat skeletal muscle sodium channels containing the
F1304Q mutation. Biophys. J. 71:1285–1294.
Liu, L., D. J. Wendt, and A. O. Grant. 1994. Relationship between structure
and sodium channel blockade by lidocaine and its amino-alkyl deriva-
tives. J. Cardiovasc. Pharmacol. 24:803–812.
Neher, E. 1983. The charge carried by single-channel currents of rat
cultured muscle cells in the presence of local anesthetics. J. Physiol.
(Lond.). 339:663–678.
Nitta, J.-I., A. Sunami, F. Marumo, and M. Hiraoka. 1992. States and sites
of actions of flecainide on guinea-pig cardiac sodium channels. Eur.
J. Pharmacol. 214:191–197.
Sanchez-Chapula, J., Y. Tsuda, and I. R. Josephson. 1983. Voltage- and
use-dependent effects of lidocaine on sodium current in rat single
ventricular cells. Circ. Res. 52:557–565.
Starmer, C. F., and A. O. Grant. 1985. Phasic ion channel blockade: a
kinetic and parameter estimation procedure. Mol. Pharmacol. 28:
348–356.
Starmer, C. F., V. V. Nesterenko, A. I. Undrovinas, A. O. Grant, and L. V.
Rosenshtraukh. 1991. Lidocaine blockade of continuously and tran-
siently accessible sites in cardiac sodium channels. J. Mol. Cell Cardiol.
23(Suppl 1):73–83.
Strichartz, G. R. 1973. The inhibition of sodium currents in myelinated
nerve by quaternary derivatives of lidocaine. J. Gen. Physiol. 62:37–57.
Sunami, A., Z. Fan, J.-I. Nitta, and M. Hiraoka. 1991. Two components of
use-dependent block of Na current by disopyramide and lidocaine in
guinea-pig ventricular myocytes. Circ. Res. 68:653–661.
Vedantham, V., and S. C. Cannon. 1999. The position of the fast-
inactivation gate during lidocaine block of voltage-gated Na channels.
J. Gen. Physiol. 113:7–16.
Wang, G. K., M. S. Brodwick, and D. C. Eaton. 1987. Inhibition of sodium
currents by local anesthetics in chloramine-T-treated squid axons.
J. Gen. Physiol. 89:645–667.
Wasserstrom, J. A., K. Liberty, J. Kelly, P. Santucci, and M. Myers. 1993.
Modification of cardiac Na channels by batrachotoxin: effects on
gating, kinetics, and local anesthetic binding. Biophys. J. 65:386–395.
West, J. W., D. E. Patton, T. Scheuer, Y. Wang, A. L. Goldin, and W. A.
Catterall. 1992. A cluster of hydrophobic amino acid residues required
for fast Na-channel inactivation. Proc. Natl. Acad. Sci. USA. 89:
10910–10914.
Yeh, J. Z., and R. Ten-Eick. 1987. Molecular and structural basis of resting
and use-dependent block of sodium current defined using disopyramide
analogues. Biophys. J. 51:123–135.
Zaborovskaya, L. D., and B. I. Khodorov. 1984. The role of inactivation in
the cumulative blockage of voltage-dependent sodium channels by local
anesthetics and antiarrhythmics. Gen. Physiol. Biophys. 3:517–520.
Zilberter, Y. I., C. F. Starmer, and A. O. Grant. 1994. Sodium channel
blockade: multiple rest states revealed by channel interactions with
disopyramide and quinidine. Am. J. Physiol. Heart Circ. Physiol. 266:
H2007–H2017.
Block of Inactivation-Deficient Na Channels 3035
Biophysical Journal 79(6) 3019–3035
